Skip to content

Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation

Tobacco

The purpose of this trial is to test whether clients of Sun Life are willing to join in a quit smoking program that offers counselling and tobacco cessation products to all participants over a 12-month period. The study team will track the safety and usage of 3 types of cessation products as well as the effectiveness of a virtual pharmacy (i.e. cessation products delivered to participants directly from a pharmacy) over a 12-week treatment period.

The purpose of this study is to look at 3 approved smoking cessation products used in combination with counselling and virtual delivery of the smoking cessation products. The goal is to track product usage, safety, and adherence (how much of the products people use and how many counselling sessions they complete).

Within the study there will also be an observational group who will not receive study medication but who will receive free virtual coaching and follow-up for smoking cessation and complete study questionnaires.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

* Adults (≥18 years)
* Current cigarette smokers (more than 5 cigarettes per day) who are interested in reducing or quitting in the next 6 months.
* Able to provide informed consent.
* Living in Ontario, Canada

Exclusion Criteria:

* Contraindications to any of the study medications (NRT, cytisine, varenicline).
* Actively using one of the study medications in the past 7 days.
* Actively enrolled in another formal smoking cessation program.
* Pregnant or breastfeeding individuals.
* Unable to engage in follow-up for any reason (for example an acute mental illness, cognitive impairment, unable to speak English or French).
* Other conditions deemed by the study team to interfere with participation or outcomes in the opinion of the study investigator (for example acutely unwell, life expectancy less than 1 year).

Lieu de l'étude

University of Ottawa Heart Institute
University of Ottawa Heart Institute
Ottawa, Ontario
Canada

Contactez l'équipe d'étude

Backup Contact

Leah Margetson

[email protected]
613-696-7000
Primary Contact

Evyanne Quirouette

[email protected]
613-696-7000
Étude parrainée par
Ottawa Heart Institute Research Corporation
Participants recherchés
Plus d'informations
ID de l'étude: NCT06832085